CFTR and cystic fibrosis: Overall, these findings suggest that although progressive insulin deficiency remains a major determinant of nutritional decline in CF, advances in clinical care and CFTR modulator therapies have substantially improved baseline nutritional and metabolic status, reflecting the evolving clinical landscape of modern CF management.